期刊文献+

平消胶囊对乳腺癌多药耐药基因P-gp、TOPOⅡ和GST-π表达调控的研究 被引量:5

Study on the effect of Pingxiao capsule on multidrug resistant gene P-gp,TOPO Ⅱ and GST-π for breast cancer
下载PDF
导出
摘要 目的通过平消胶囊对新辅助化疗乳腺癌疗效及对耐药基因P-gp、TOPOⅡ和GST-π的调控研究,探索扶正解毒中药对化疗增效的作用机制。方法将60例需行新辅助化疗的乳腺癌患者随机分为治疗组与对照组,在应用相同化疗方案的基础上,治疗组同时服用扶正解毒中药平消胶囊,对照组不服用。3周期后观察2组实体瘤的改善情况,并检测乳腺癌组织P-gp、TOPOⅡ和GST-π的表达,并进行组间比较。结果治疗组完全缓解率为13.3%,部分缓解率为63.3%;对照组完全缓解率为3.3%,部分缓解率为40%,2组比较有显著性差异(P<0.05)。化疗后治疗组P-gp、TOPOⅡ和GST-π阳性表达率分别为36.7%,36.7及30%,对照组的相应为66.7%,40%及56.6%,两组间TOPOⅡ表达无显著差异,治疗组P-gp和GST-π表达较对照组显著降低。结论扶正解毒中药可增强化疗的效果,调控多药耐药基因的表达可能是其重要的作用机制。 Objective To investigate the mechanism of Chinese drugs in increasing the curative effect of chemotherapy by observing the effect of Pingxiao capsules on neoadjuvant chemotherapy and multidrug resistant gene P-gp,TOPOⅡand GST-π for breast cancer.Methods Sixty patients receiving neoadjuvant chemotherapy were divided into treatment group and control group.Pingxiao capsules treatment was added to the treatment group but it was not used in control group.The improved atatus of local tumor was observed and the expression of P-gp,TOPOⅡand GST-π in tumor tissue were compared between two groups after three therapeutic cycles.Results The complete remission rate(CR) of study group was 13.3% and partial remission rate was 63.3,while the figures were 3.3% and 40% in control group and there was obvious statistical differences between two groups(P0.05).The positive rate of P-gp,TOPOⅡand GST-π were 36.7%,36.7and 30% in study group and 66.7%,40% and 56.6% in control group after chemotherapy.There was no statically difference in TOPOⅡ expression between two groups.The P-gp and GST-π expressions were significantly lower in study group than control group.Conclusion Detoxicating and strengthening the body resistance Chinese drugs would enhance the chemotherapeutic effects.The Multi-drugs resistance gene expressions are regulated,which it may be important mechanism of action.
出处 《岭南现代临床外科》 2011年第1期38-40,共3页 Lingnan Modern Clinics in Surgery
关键词 乳腺癌 P鄄糖蛋白 拓扑异构酶 谷胱甘肽鄄S鄄转移酶 免疫组织化学 Breast cancer、P-glycoprtoein、TOPOⅡ、GST-π、Immunohistochemistry
  • 相关文献

参考文献7

  • 1Dirven HAAM,Dictus ELJT,Broeders NLHL,et al.The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa. Cancer Research . 1995
  • 2李豫江,李志刚,吴涛.乳腺癌术前行平消胶囊联合化疗疗效观察[J].现代肿瘤医学,2005,13(2):260-262. 被引量:10
  • 3Huang J,Tan PH,Thiyagarajan J,et al.Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Modern Pathology . 2003
  • 4Bellamy CO,Harrison DJ.Evaluation of glutathione Stransferase Pi in non-invasive ductal carcinoma of breast. British Journal of Cancer . 1994
  • 5李恩孝,李毅,杨谨,何静,陈玲,王建波,周小娟,李蓉.转移性乳腺癌P-糖蛋白表达与化疗疗效的关系[J].癌症,2002,21(4):430-432. 被引量:3
  • 6Tsuruo T.Molecular cancer therapeutics: recent progress and targets in drug resistance. Journal of Internal Medicine . 2003
  • 7Serafino A,Sinibaldi Vallebona P,Gaudiano G,et al.Cyto-plasmic localization of anthracycline antitumor drugs conjugat-ed with reduced glutathione:a possible correlation with mul-tidrug resistance mechanisms. Anticancer Research . 1998

二级参考文献13

  • 1Ueda K,Yoshida A,Amachi T.Recent progress in p glycoprotein research [J].Anticancer Drug Des,1999,14:115- 121.
  • 2Leonardo E,Valente G,Cappia S,et al.Immunohistochemical evaluation of P glycoprotein in human malignancies by monoclonal antibody MC57[J].Int J Cancer,1994,57:841- 846.
  • 3Trock BJ,Leonessa F,Clarke R.Multidrug resistance in breast cancer: a meta analysis of MDR1/gp170 expression and its possible functional significance [J].J Natl Cancer Inst,1997,89:917- 931.
  • 4Linn SC,Honkoop AH,Hoekman K,et al.p53 and P glycoprotein are often co expressed and are associated with poor prognosis in breast cancer [J].Br J Cancer,1996,74:63- 68.
  • 5Early Breast Cancer Trialists Collaborative Group.Polychemotherapy for early breast cancer: an overview of the randomised trials [J].Lancet,1998,352:930- 942.
  • 6Leyland JB,Dalton W,Fisher GA,et al.Reversal of multidrug resistance to cancer chemotherapy [J].Cancer,1993,72:3484- 3488.
  • 7Mamoounas EP, Fisher B. Preoperative chemotherapy for operable breast cancer [J]. Cancer Treat Res,2000,103:137 ~ 155.
  • 8Sapunar F, Smith IE. Neoadjuvant chemotherapy for breast cancer [J]. Ann Med,2000,32(1):43~50.
  • 9袁秉祥,高文,范桂香,等.平消胶囊对荷瘤动物肿瘤生长的抑制作用[C].平消胶囊研究进展.1997,17~33.
  • 10陈惠黎,杨秉辉.肿瘤标志及其他实验室检查[A].汤钊猷.现代肿瘤学[M].上海:上海医科大学出版社,1993.263.

共引文献11

同被引文献150

引证文献5

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部